Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

NCT01794429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Metabolic Syndrome X
Drug-induced Obesity
Schizophrenia

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

Bjorn H. Ebdrup